RecruitingNot applicableNCT04179383
Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome
Studying Reversible cerebral vasoconstriction syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Montpellier
- Principal Investigator
- Lucas CORTICHU de Montpellier
- Intervention
- Constitution of a biobank(other)
- Enrollment
- 225 target
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2019 – 2024
Study locations (1)
- Gui de Chauliac Hospital, Montpellier, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04179383 on ClinicalTrials.gov